Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Analyst Ratings For Collegium Pharmaceutical
Over the past 3 months, 4 analysts have published their opinion on Collegium Pharmaceutical (NASDAQ:COLL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Needham Maintains Buy on Collegium Pharmaceutical, Raises Price Target to $36
Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $34 to $36.
Why Collegium Pharmaceutical’s Shares Are Trading Higher Today
Collegium Pharmaceutical Inc (NASDAQ:COLL) updated financial guidance for FY22 to include the expected impact of the BioDelivery Sciences International Inc (BDSI)…
A Look Into Healthcare Sector Value Stocks
The Meaning Behind Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
Piper Sandler Maintains Overweight on Collegium Pharmaceutical, Raises Price Target to $42
Piper Sandler analyst David Amsellem maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Overweight and raises the price target from $36 to $42.